Clinical trials: PET-CT
Lung Cancer
Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung Cancer
The purpose of this study is to evaluate the use of Dynamic PET/CT as a tool to assess disease response to anti-cancer therapy in Lung Cancer patients.
- Trial name
- NCT02505685
- Where
- Israel
- Volunteers
- 200 people
- Sponsor
- Rabin Medical Center
Clear Cell Renal Cell Carcinoma
68Ga-NY104 PET/CT in Patients With Metastasis/Recurrence Clear Cell Renal Cell Carcinoma Suspicion
This is a prospective, single-center, single-arm phase 2 study in patients with clear cell renal cell carcinoma and metastasis or recurrence suspicion.
- Trial name
- NCT05879497
- Testing
- 68Ga-NY104 PET/CT
- Where
- China
- Volunteers
- 40 people
- Sponsor
- Peking Union Medical College Hospital
Cardiac Inflammation
Heart Analysis in GATED-PET in Patients Having a Gallium-68-DOTATOC PET/CT Exam for Oncology Indication
Gallium-68-DOTATOC binds primarily with high affinity to somatostatin subtype 2 (SSTR2) receptors and these somatostatin receptors are also overexpressed on inflammation cells when activated.
- Trial name
- GATEDOTA (NCT06467968)
- Testing
- Cardiac ECG-gated PET imaging will added
- Where
- France
- Volunteers
- 99 people
- Sponsor
- Central Hospital, Nancy, France
Colorectal Cancer
Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT
Measuring tumor response to treatment based on computed tomography (CT) and/or magnetic resonance imaging (MRI) has been a widely debated issue (response criteria in solid tumors [RECIST] and World Health Organization criteria).
- Trial name
- RESCORE (NCT00823810)
- Testing
- PET/CT
- Where
- Finland
- Volunteers
- 20 people
- Sponsor
- Turku University Hospital
Lung Cancer, Lung Diseases
Comparison of Robotic Arm-assisted PET/CT-guided Lung Biopsy With PET Fused CT- Fluoroscopy-guided Lung Biopsy
Patients with suspicious lung lesions were undertaken for PET/CT directed under CT fluoroscopy lung biopsy or robotic-assisted biopsy.
- Conditions
- Lung Cancer, Lung Diseases, Adenocarcinoma of Lung
- Trial name
- NCT05245630
- Testing
- Robotic arm assisted PET/CT guided biopsy, PET fused CT-Fluoroscopy guided biopsy
- Where
- India
- Volunteers
- 59 people, healthy volunteers welcome
- Sponsor
- Post Graduate Institute of Medical Education and Research, Chandigarh
Carcinoma, Squamous Cell
Determine Tumor Response Using Fluorodeoxyglucose (FDG)- Positron Emission Tomography (PET)/Computed Tomography (CT) Before and After Cetuximab in Patients With Head and Neck Cancer
The purpose of this study is to collect data and evaluate how the tumor is broken down in response to standard of care cetuximab treatment by evaluating the FDG-PET/CT scans, toxicity, see how well the FDG-PET/CT scans predict…
- Trial name
- SCCHN (NCT00671437)
- Testing
- FDG-PET/CT, Cetuximab
- Where
- 2 sites in United States
- Volunteers
- 42 people
- Sponsor
- Washington University School of Medicine
SSTR-related Disease, Tumor
Somatostatin Receptor PET/CT in SSTR-Related Disease Patients
To evaluate the potential usefulness of 68Ga/18F-TATE/JR11/LM3 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various SSTR-related disease patients.
- Conditions
- SSTR-related Disease, Tumor, Positron Emission Tomography, Metastasis
- Trial name
- NCT06690957
- Testing
- 68Ga/18F-TATE/JR11/LM3
- Where
- 3 sites in China
- Volunteers
- 500 people, healthy volunteers welcome
- Sponsor
- Tianjin Medical University
Prostate Cancer, Hepatocellular Carcinoma
68Ga-FAPI-PSMA PET Imaging for the Diagnosis of Solid Tumors
This study aims to evaluate a novel dual-targeted PET imaging tracer, 68Ga-FAPI-PSMA, for the detection and evaluation of solid tumors.
- Conditions
- Prostate Cancer, Hepatocellular Carcinoma, Ovarian Cancer, Solid Tumors
- Trial name
- NCT07639801
- Testing
- 68Ga-FAPI-PSMA, 68Ga-PSMA-617, 68Ga-FAPI-04
- Volunteers
- 20 people
- Sponsor
- Peking University Cancer Hospital & Institute
Diabetic Autonomic Neuropathy, Gastrointestinal Motility Disorder
Gastrointestinal Motility Among Diabetes Patients
Gastrointestinal (GI) symptoms including vomiting, nausea, abdominal pain, constipation or chronic diarrhea affect a large number of patients with diabetes mellitus (DM).
- Conditions
- Diabetic Autonomic Neuropathy, Gastrointestinal Motility Disorder, Diabetes Mellitus, Change of Transit or Circulation
- Trial name
- NCT02573519
- Testing
- 11C Donepezil PET/CT scan, 3D-Transit, 3D-Transit during treatment with Pyridostigmine
- Where
- Denmark
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Aarhus
Neuroendocrine Carcinoma
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
To evaluate the concordance and discordance between results of 68Ga-DOTATATE PET-CT scan and OctreoScan ® which is considered standard of care diagnostic test for neuroendocrine cancers and other imaging modalities like CT…
- Trial name
- NCT01879657
- Testing
- 68Ga-DOTATATE, PET/CT, 111In-pentetreotide OctreoScan
- Where
- United States
- Volunteers
- 169 people
- Sponsor
- Radio Isotope Therapy of America
Prostate Cancer
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
This study will be assessing the ability of PSMA-PET CT to determine the absence of clinically significant prostate cancer in patients on active surveillance (AS) with low risk and favorable intermediate-risk prostate cancer.
- Trial name
- ESCAPE (NCT05948657)
- Testing
- PSMA-PET CT
- Where
- 4 sites in United States
- Volunteers
- 200 people
- Sponsor
- Weill Medical College of Cornell University
Cancer
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.
- Trial name
- NCT07059832
- Testing
- 68Ga-NODAGA-SNA006
- Where
- China
- Volunteers
- 30 people
- Sponsor
- First Hospital of China Medical University
Prostate Cancer, Cryotherapy
Salvage Cryotherapy for Recurrent Prostate Cancer After Radiation Therapy
The main objective of this project is to establish a shared comprehensive and systematic protocol for a multicenter prospective registry of patients undergoing salvage cryoablation of the prostate (SCAP).
- Conditions
- Prostate Cancer, Cryotherapy, Recurrent Prostate Cancer
- Trial name
- CRIOAND2021 (NCT04891536)
- Testing
- Salvage cryoablation of the prostate (SCAP)
- Where
- 2 sites in Spain
- Volunteers
- 100 people
- Sponsor
- Ignacio Puche Sanz
Kidneys
Cardio and Renovascular Effects of Isometric Exercise in the Healthy Human Measured by PET/CT and MRI
This randomized crossover study aims to validate measurements of renal perfusion in healthy males with PET/CT, using 15-oxygen labeled water as tracer, against the validated multiparametric MRI technique.
- Trial name
- NCT06555211
- Testing
- MRI, PET/CT
- Where
- Denmark
- Volunteers
- 10 people, healthy volunteers welcome
- Sponsor
- Bispebjerg Hospital
Infective Endocarditis
Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis
Study hypothesis: 68Ga-DOTATOC PET/CT could detect cardiac foci of infective endocarditis regardless of the type of valve (native or prosthetic) and also extracardiac localizations related to this pathology (infection…
- Trial name
- DOTENDO (NCT05183555)
- Testing
- 68Ga-DOTATOC PET/CT
- Where
- France
- Volunteers
- 14 people
- Sponsor
- Central Hospital, Nancy, France
Tumor
68Ga-FAPI-Biotin PET/CT in Patients With Various Types of Cancer
As a new dual targeting PET radiotracer, 68Ga-FAPI-Biotin is promising as an excellent imaging agent applicable to various cancers.
- Trial name
- NCT06740240
- Testing
- 68Ga-FAPI-Biotin, 68Ga-FAPI/18F-FDG
- Where
- China
- Volunteers
- 30 people
- Sponsor
- First Affiliated Hospital of Fujian Medical University
Cancer
FDG Uptake in Vaginal Tampons is Due to Urine
The etiology of FDG uptake in vaginal tampons during PET/CT examinations remains unclear and can potentially impair image interpretation.
- Trial name
- NCT01215318
- Testing
- modified vaginal tampon
- Where
- Switzerland
- Volunteers
- 44 people
- Sponsor
- Irene Burger
Sarcoidosis
Optimizing Acquisition Parameters and Interpretive Methods of FDG-PET/CT With Rb-82
In this this investigation, 15 subjects with a high probability of cardiac sarcoidosis based on clinical criteria and abnormal cardiac FDG uptake on initial, clinically indicted FDG PET study will be considered for this study.
- Trial name
- NCT03048097
- Testing
- Fluorodeoxyglucose, Rubidium, FDG-PET/CT with Rb82 Myocardial Perfusion Imaging
- Where
- United States
- Volunteers
- 15 people
- Sponsor
- Yale University
Pleural Effusion, Malignant
The Value of PET-CT in Pleural Effusions
The investigators aim is to asses the diagnostic power of 18F-FDG PET-CT in discriminating malignant from nonmalignant causes in patients with a recurrent unilateral pleural effusion of unknown origin.
- Trial name
- NCT03272997
- Where
- Denmark
- Volunteers
- 112 people
- Sponsor
- Naestved Hospital
Breast Cancer
Characterizing Breast Cancer With Al18F-NOTA-FAPI-04 PET/CT (PFB-02)
Fibroblast activation protein (FAP) is overexpressed in cancer-associated fibroblasts (CAFs), which constitute a major proportion of cells within the tumor microenvironment, especially in breast cancer.
- Trial name
- NCT05574920
- Testing
- Al18F-NOTA-FAPI-04 PET/CT scan
- Where
- China
- Volunteers
- 88 people
- Sponsor
- Peking Union Medical College Hospital
The first 1,020 results can be paged through. Add a filter or change the sort order to reach the rest.